252 Rationale and study design of the KOV-HIPEC-02 trial: a randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer

Kim, Ji Hyun; Park, Eun‐Young; Jeong, Dae Hoon; Lee, Yoo-Young; Choi, Chel Hoon; Chung, Hyun Hoon; Lee, Taek Sang; Jeon, Hye Won; Lee, Shin‐Wha; Park, Jeong‐Yeol

doi:10.1136/ijgc-2024-esgo.1102

252 Rationale and study design of the KOV-HIPEC-02 trial: a randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer

Ji Hyun Kim, Eun‐Young Park, Dae Hoon Jeong, Yoo-Young Lee and 6 more

Ji Hyun Kim

NobleIDNI4P36W33R98S21

Type:Journal Article

Claim Your Authorship

Sign in to see the full record

Creating an account is free.

Create an account

For data access, contact info@nobleid.org.

252 Rationale and study design of the KOV-HIPEC-02 trial: a randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer | NobleID